No adverse event reporting system exists for tattoo reactions

When a client develops a severe allergic reaction, infection, or granuloma from a tattoo, there is no mandatory reporting mechanism that feeds back to any regulatory body or public health database. The FDA's MedWatch system accepts voluntary reports, but tattoo artists are not required to report adverse events, clients do not know MedWatch exists, and dermatologists treating tattoo reactions have no obligation to report them either. So what? Without systematic data collection, no one knows the true incidence rate of tattoo adverse reactions. Estimates range wildly from 0.5% to 6% of tattooed individuals, but these are based on small survey studies, not actual surveillance data. So what? The FDA uses the absence of reported adverse events as justification for not regulating tattoo inks more aggressively -- the same circular logic that has maintained the regulatory gap for decades. So what? When contaminated ink batches cause infection clusters, the connection is often not identified for months because each case is treated in isolation by different doctors in different cities, with no centralized system connecting the dots. The 2012 Mycobacterium chelonae outbreak was only identified because an unusually alert dermatologist in Rochester, NY noticed a cluster pattern. This persists because the Modernization of Cosmetics Regulation Act (MoCRA, 2022) technically requires adverse event reporting for cosmetics including tattoo inks, but implementation and enforcement infrastructure has not been built.